Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Product News
New Additions to Malvern Instruments’ ‘10 ways to…’ Whitepaper Series
Saturday, October 11, 2014
Two new additions to whitepaper series guide rheological optimization of dispersion products.

High Throughput Biological Sample Concentrator
Tuesday, September 16, 2014
The miVac Quattro from Genevac is the perfect workhorse sample concentrator for biological laboratories tasked with handling larger numbers of samples.

PerkinElmer Launches Innovative Solaris™ Optical Imaging System
Thursday, September 11, 2014
Fluorescence technology for small and large animal imaging advances translational and preclinical research applications.

Malvern Technology Delivers Malvern Reliability in Multi-disciplinary Lab
Wednesday, September 10, 2014
The Zetasizer Nano, NanoSight NTA and Mastersizer 2000 systems employed within the Queen Mary University London lab.

Meet SeedEZ, a universal 3D cell culture drug screening system
Sunday, September 07, 2014
Lena Biosciences introduces a robust and easy to use SeedEZ 3D cell culture drug screening system supporting consistent yet complex 3D cell culture, co-culture and multilayered tissue models with immune and inflammatory components.

Selvita Licenses Cresset’s Forge and Spark
Thursday, September 04, 2014
Computational tools for SAR analysis and ligand-based design.

Easy-to-use, Quantitative Gamma-H2AX Assay
Tuesday, September 02, 2014
Gamma H2AX pharmacodynamic assay kit for the study of double strand DNA breaks.

Whitehouse Scientific’s ShapeSizer Image Analyser Takes a ‘Grand Tour’
Wednesday, August 20, 2014
CEO of calibration standards company Whitehouse Scientific, has completed a lecture tour of Europe, travelling in style and accompanied by the company’s ShapeSizer Image Analyser.

Optibrium Launches SentiraTM: New Software for Compound Data Visualisation
Monday, August 11, 2014
Powerful desktop application simplifies visualisation, interpretation and presentation of compound data.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 668
Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters